Literature DB >> 1547804

Serial assessment of denervated but viable myocardium following acute myocardial infarction in dogs using iodine-123 metaiodobenzylguanidine and thallium-201 chloride myocardial single photon emission tomography.

T Nishimura1, H Oka, M Sago, T Matsuo, T Uehara, H Noda, H Takano.   

Abstract

Iodine-123 metaiodobenzylguanidine (mIBG) is taken up by sympathetic nerve endings, allowing scintigraphic imaging of myocardial sympathetic innervation. We investigated the denervated but viable canine myocardium after acute myocardial infarction by serial mIBG and thallium-201 chloride (201TlCl) single photon emission tomography (SPET). In 12 dogs, acute myocardial infarction was produced by ligation of the left circumflex coronary artery. Images of mIBG and thallium SPET were obtained 6 h, 1, 4 and 6 weeks later. The defect size was calculated in percentage points from short axial views, and the 123I-mIBG/201TlCl ratio was determined. The uptake ratio was high at 1 week but gradually decreased. Three dogs were killed at each time point, and tissue samples were obtained from infarcted (both 201TlCl and 123I-mIBG defects), peri-infarcted (123I-mIBG defect and 201TlCl normal) and normal myocardium (both mIBG and 201TlCl normal). The changes in tissue content of noradrenaline in these lesions were measured. Noradrenaline tissue content gradually recovered in the peri-infarcted area. However, no recovery was noted in the infarcted area at 6 weeks. We conclude that sympathetic denervation and re-innervation occur following acute myocardial infarction, and the denervated but viable myocardium could be detected non-invasively by combined mIBG and thallium SPET.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1547804     DOI: 10.1007/bf00178304

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  10 in total

1.  Scintigraphic assessment of regional cardiac adrenergic innervation.

Authors:  M W Dae; J W O'Connell; E H Botvinick; T Ahearn; E Yee; J P Huberty; H Mori; M C Chin; R S Hattner; J M Herre
Journal:  Circulation       Date:  1989-03       Impact factor: 29.690

2.  Changes in norepinephrine stores in the canine heart following experimental myocardial infarction.

Authors:  P Mathes; S Gudbjarnason
Journal:  Am Heart J       Date:  1971-02       Impact factor: 4.749

3.  Heart imaging in the diagnosis of pheochromocytoma and assessment of catecholamine uptake.

Authors:  W M Manger; B B Hoffman
Journal:  J Nucl Med       Date:  1983-12       Impact factor: 10.057

4.  Transmural myocardial infarction in the dog produces sympathectomy in noninfarcted myocardium.

Authors:  M J Barber; T M Mueller; D P Henry; S Y Felten; D P Zipes
Journal:  Circulation       Date:  1983-04       Impact factor: 29.690

5.  Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine.

Authors:  M S Stanton; M M Tuli; N L Radtke; J J Heger; W M Miles; B H Mock; R W Burt; H N Wellman; D P Zipes
Journal:  J Am Coll Cardiol       Date:  1989-11-15       Impact factor: 24.094

6.  Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function.

Authors:  J C Sisson; D M Wieland; P Sherman; T J Mangner; M C Tobes; S Jacques
Journal:  J Nucl Med       Date:  1987-10       Impact factor: 10.057

7.  Scintigraphic and electrophysiological evidence of canine myocardial sympathetic denervation and reinnervation produced by myocardial infarction or phenol application.

Authors:  J D Minardo; M M Tuli; B H Mock; R E Weiner; H P Pride; H N Wellman; D P Zipes
Journal:  Circulation       Date:  1988-10       Impact factor: 29.690

8.  Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart.

Authors:  M Nakajo; K Shimabukuro; H Yoshimura; R Yonekura; Y Nakabeppu; P Tanoue; S Shinohara
Journal:  J Nucl Med       Date:  1986-01       Impact factor: 10.057

9.  Myocardial imaging in man with I-123 meta-iodobenzylguanidine.

Authors:  R C Kline; D P Swanson; D M Wieland; J H Thrall; M D Gross; B Pitt; W H Beierwaltes
Journal:  J Nucl Med       Date:  1981-02       Impact factor: 10.057

10.  Scintigraphic detection of regional disruption of adrenergic neurons in the heart.

Authors:  J C Sisson; J J Lynch; J Johnson; S Jaques; D Wu; G Bolgos; B R Lucchesi; D M Wieland
Journal:  Am Heart J       Date:  1988-07       Impact factor: 4.749

  10 in total
  8 in total

Review 1.  MIBG imaging.

Authors:  Amar D Patel; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

Review 2.  Cardiac neurotransmission SPECT imaging.

Authors:  Albert Flotats; Ignasi Carrió
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

3.  Role of cardiac nuclear imaging in the management of critically ill patients.

Authors:  Alia Fattah
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-09       Impact factor: 9.236

4.  Assessment of acute thrombolysis with newly developed myocardial single-photon emission computed tomographic techniques.

Authors:  T Nishimura
Journal:  J Nucl Cardiol       Date:  1995 Mar-Apr       Impact factor: 5.952

Review 5.  Transfer from PET to SPET in cardiology, but the unit of reference is still the patient.

Authors:  O Schober; E Moser
Journal:  Eur J Nucl Med       Date:  1994-06

6.  How do we establish cardiac sympathetic nervous system imaging with 123I-mIBG in clinical practice? Perspectives and lessons from Japan and the US.

Authors:  Mark I Travin; Ichiro Matsunari; Gregory S Thomas; Kenichi Nakajima; Keiichiro Yoshinaga
Journal:  J Nucl Cardiol       Date:  2018-09-03       Impact factor: 5.952

7.  Noradrenaline depletion in patients with coronary artery disease before and after percutaneous transluminal coronary angioplasty with iodine-123 metaiodobenzylguanidine and single-photon emission tomography.

Authors:  C Guertner; H Klepzig; F D Maul; A Hartmann; S Lelbach; A Hellmann; G Hoer
Journal:  Eur J Nucl Med       Date:  1993-09

8.  Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy.

Authors:  O Schnell; C M Kirsch; J Stemplinger; M Haslbeck; E Standl
Journal:  Diabetologia       Date:  1995-11       Impact factor: 10.122

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.